is qsymia a glp-1 Daily Medication Pearl: Phentermine and Topiramate ER (Qsymia) Qsymia for Medical Weight Loss

In summary, observational studies have not found an increased risk of PDAC during short term follow-up

As well as an increase in the practical use of sportswear for exercise purposes, there may be a rush to join the athleisure craze as suggested by a BMO Capital Markets analysis

The company serves both employers and individuals with services spanning urgent care, behavioral health, physical therapy, and chronic condition management

In late 2025, the FDA approved an oral semaglutide formulation (Wegovy oral) for weight management at 25mg and 50mg doses, with clinical trials showing 13-14% body weight reduction

Orskov C, Poulsen SS, Moller M, Holst JJ

On April 30, 2026, the FDA moved further - formally proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List entirely, citing no clinical need for large-scale outsourcing facilities to compound these drugs from bulk substances